Transferrin (human, recombinant)

Transferrin (human, recombinant)

CAT N°: 32030
Price:

505.00 429.25

Transferrin is a glycoprotein that binds and transports ferric iron.{46988,46990} It is a 679-amino acid bilobal protein composed of N- and C-terminal lobes, each housing a ferric iron binding site, connected by a seven-amino acid bridge.{46988} Transferrin is predominately synthesized in hepatocytes, but is also expressed in Sertoli, ependymal, oligodendroglial, and metastatic melanoma cell lines, and is secreted into the circulation.{46988,46990} Iron-containing transferrin binds to the transferrin receptor (TfR1; Item No. 32031) on the surface of iron-requiring cells to form the transferrin/TfR complex, which undergoes clathrin-dependent endocytosis to facilitate intracellular iron release. The transferrin/TfR complex is then returned to the cell surface and apo-transferrin is released back into the circulation via dissociation or displacement by an iron-containing transferrin.{46988} Immunodepletion of transferrin inhibits serum-induced ferroptosis of Bax and Bak double knockout mouse embryonic fibroblasts (MEFs), indicating that transferrin is a regulator of ferroptosis.{43380} Exogenous administration of apo-transferrin to three-day-old rats increases expression of myelin constituents and enhances myelinogenesis in myelin-deficient rats.{46991} It also normalizes labile plasma iron concentrations and red blood cell survival, increases hemoglobin production, and decreases reticulocytosis and splenomegaly in the Hbbth1/th1 mouse model of ?-thalassemia.{46989} Cayman’s Transferrin (human, recombinant) protein can be used for ELISA and cell-based assay applications. This protein consists of 690 amino acids, has a calculated molecular weight of 76.6 kDa, and a predicted N-terminus of Val20 after signal peptide cleavage.

We also advise you

TAF 10 Peptide

TAF 10 Peptide

TAF10 is one of many protein factors or coactivators associated with RNA polymerase II activity.{16903} One vial of this peptide...

€191.00
View